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Rift Valley fever virus is a significant human and veterinary pathogen responsible for explosive outbreaks throughout Africa and the Arabian
Peninsula. Severe acute disease in humans includes rapid onset hepatic disease and hemorrhagic fever or delayed onset encephalitis. A highly
efficient reverse genetics system was developed which allowed generation of recombinant RVF viruses to assess the role of NSm protein in
virulence in a rat model in which wild-type RVF virus strain ZH501 (wt-ZH501) results in 100% lethal hepatic disease 2–3 days post infection.
While extensive genomic analysis indicates conservation of the NSm coding capability of diverse RVF viruses, and viruses deficient in NSs
proteins are completely attenuated in vivo, comparison of wt-ZH501, a reverse genetics generated wt-ZH501 virus (R-ZH501), and R-ZH501
virus lacking the NSm proteins (R-ΔNSm-ZH501) demonstrated that the NSm proteins were nonessential for in vivo virulence and lethality.
Surprisingly, while 44% of R-ΔNSm-ZH501 infected animals quickly developed lethal hepatic disease similar to wt- and R-ZH501, 17%
developed delayed onset neurologic disease (lethargy, head tremors, and ataxia) at 13 days post infection. Such infections may provide the basis
for study of both RVF acute hepatic disease and delayed onset encephalitic disease in humans.
Published by Elsevier Inc.Keywords: Rift Valley fever virus; NSm protein; Viral virulence factors; Bunyaviridae; Phlebovirus; Pathogenesis; Recombinant virus; Molecular pathogenesis;
Reverse genetics; Hemorrhagic fever; Acute hepatic disease; Delayed neurologic disease; Rat modelIntroduction
Rift Valley fever (RVF) virus (family Bunyaviridae genus
Phlebovirus) is a mosquito-borne pathogen of humans and
livestock historically capable of either low level endemic
activity or large explosive epidemics/epizootics throughout
Africa (Swanepoel and Coetzer, 1994; Nichol, 2001) and more
recently in the Arabian peninsula (Madani et al., 2003). Severe
hepatic destruction can be seen in livestock, leading to high
mortality and abortion rates in susceptible species. Most human
infections result in an acute febrile flu-like illness, but rapid
onset hepatic disease with hemorrhagic symptoms and late
onset severe encephalitis are seen in 1–2% of cases (Meegan et
al., 1981; Swanepoel and Coetzer, 1994; Madani et al., 2003).⁎ Corresponding author. Fax: +1 404 639 1118.
E-mail address: stn1@cdc.gov (S.T. Nichol).
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2007.01.046The negative sense tripartite RNA genome of RVF virus is
comprised of the small ambisense (S) segment that encodes the
viral nucleoprotein (NP) in genomic (−) orientation and in anti-
genomic (+) orientation the non-structural (NSs) protein which
is a major virulence factor functioning as a potent antagonist of
host cell RNA Pol II transcription (Billecocq et al., 2004), and
the large (L) segment encodes the virus polymerase (Schmal-
john and Hooper, 2001). A notable feature of the RVF virus M
segment is the presence of 5 in-frame AUG-methionine start
codons within the NSm protein coding region at antigenomic
sense positions #21, 135, 174, 411, and 426 that occur prior to
the signal peptidase cleaveage site of the mature Gn protein
(Suzich et al., 1990; Gerrard and Nichol, 2007). These studies
demonstrated that alternate utilization of the in-frame AUG's at
position 21 and 135 were responsible for at least 2 forms of
glycoprotein, a 14 kDa NSm protein and a 78 kDa NSm and Gn
fusion polyprotein, respectively, in addition to the expected
Table 1
Experimental design and clinical outcome of infection of WF rats with wt-
ZH501, R-ZH501 or R-ΔNSm-ZH501 virus
Virus Virus dose (PFU) and outcome (H/N/T)* Time to
death (days)
0 101 102 103 104
wt-ZH501 n.a. 3/0/3 3/0/3 3/0/3 n.d. 2–3
R-wt-ZH501 n.a. 3/0/3 n.d. 3/0/3 n.d. 3
R-ΔNSm-ZH501 n.a. 1/1/3 2/0/3 2/1/6 3/1/6 Hepatic 4
Neuro. 13
Negative control 0/0/3 – – – – n.a.
* H=number of animals with fatal hepatic disease, N=number of animals with
fatal neurologic disease, T=total number of animals, ** n.a.=not applicable,
*** n.d.=not done.
11Rapid Communication55 kDa Gn and 58 kDa Gc envelope glycoproteins. Recent
complete genome sequencing of 33 naturally occurring RVF
virus isolates indicated complete conservation of these 5 in
frame AUG codons (Bird et al., 2007). Surprisingly, given their
highly conserved nature, recent work in this laboratory and
elsewhere, demonstrated that the NSm proteins of RVF virus
were dispensable for efficient virus growth in cell culture (Won
et al., 2006; Gerrard et al., 2007). In the present study, we
describe modification and optimization of our reverse genetics
system based on the virulent RVF virus ZH501 strain to produce
a highly efficient system for the rapid generation of recombinant
wild-type and mutant viruses lacking the entire NSm coding
region. These recombinant viruses are used to examine of the
role of the NSm 14 kDa and 78 kDa proteins in in vivo
pathogenesis in the highly susceptible Wistar-furth rat model of
lethal RVF virus infection (Anderson and Peters, 1988;
Anderson et al., 1991). In this animal model we demonstrate
that the NSm proteins (14 kDa and 78 kDa) are not essential for
in vivo virulence or lethality.
Results
Rescue of recombinant RVF viruses, R-ZH501 and
R-ΔNSm-ZH501
In a previous report (Gerrard et al., 2007), we described the
successful generation of a recombinant RVF virus, R-ΔNSm-
ZH501, lacking the NSm coding region. After careful
examination by 3′RACE and Northern Blot techniques, we
found that the original S plasmid produced low amounts of full
length S-segment genomic sense replication products, yielding
primarily short replication products encompassing the NSs gene
region only (data not shown). This finding limited the overall
efficiency of our initial attempts at the rescue of recombinant
viruses.
In order to correct this problem, full length S RNA from the
wild-type ZH501 virus strain was re-cloned into a version of the
plasmid vector V(0.0) which was modified to remove the
multiple cloning site. Within this backbone context, we
observed greatly increased levels of N protein expression
relative to the original construct. This allowed subsequent
rescue of recombinant virus without the requirement of a
support plasmid expressing the N protein as previously
described.
In addition, although they did not affect rescue efficiency,
two non-synonymous mutations in the M segment clone were
corrected to match the wt sequence to allow exact in vivo
comparisons to be made between recombinant and wild-type
viruses. These were restored in both the full length M segment
and Δ-NSm plasmids by site directed mutagenesis and
restriction fragment exchange. These changes included removal
of the XhoI restriction site (position 2136-9) we had previously
introduced and which had resulted in an amino acid coding
change from L to T, and an inadvertently introduced change at
nt. position 847 which had resulted in a change from E to G. In
order to maintain the ability to distinguish full-length
recombinant virus from the wt virus, we preserved 2 silentmutations on the M segment at positions 1706 (C to T) and 2750
(C to T).
After incorporating the above corrections, virus rescue was
accomplished by simultaneous liposome transfection of only
the 3 full length antigenomic sense plasmids (S, M, L or S, Δ-
NSm, L) in BSR-T7/5 cells. After complete lysis, cell
supernatants containing rescued viruses were clarified, diluted
and virus passaged twice on VERO E6 cells. All recombinant
viruses were found to grow similarly to wt-ZH501 in VERO E6
cell culture (Gerrard et al., 2007; Bird et al., 2007; and data not
shown). To ensure the exact molecular identity of all viruses
used in this study complete genome sequence was obtained
following techniques described elsewhere (Bird et al., 2007). As
a measure of the robustness of the optimized reverse genetics
system, we completed a total of 11 separate rescue attempts
using a variety of plasmid concentrations ranging from 0.5 ug to
4 ug and achieved 100% success in rescuing recombinant RVF
virus in each experimental replicate using only the combination
of the 3 full length S, M and L antigenomic sense plasmids or
full length S, ΔNSm, and L antigenomic sense plasmids. The
efficiency of this system is similar to that of other highly
efficient 3 plasmid systems developed earlier for other members
of the family Bunyaviridae, including Bunyamwera and La
Crosse viruses (Lowen et al., 2004; Blakqori and Weber, 2005).
Establishment of the RVF disease model using wt-ZH501 virus
In order to establish the Wistar-furth rat model of lethal RVF
virus infection (Anderson and Peters, 1988; Anderson et al.,
1991) in our laboratory, a total of 9 animals were infected in
groups of 3 with 101, 102, or 103 PFU of wt-ZH501 virus
(Table 1). A clinical feature of wt-ZH501 infection in these
animals is peracute death occurring 2–3 days post infection
(PI) due to fulminant hepatitis. Animals are reported to be
clinically healthy until approximately 12 h prior to death,
quickly followed by animals developing clinical signs of illness
and rapidly succumbing due to hepatic injury. All animals
infected with wt-ZH501 virus in our study remained clinically
healthy until just prior (∼12 h) to death. On day 2 PI 2 animals
(1 each in 102 and 103 PFU dose groups) were found dead (Fig.
1). Gross pathology at necropsy indicated extensive diffuse
hepatic necrosis with no other significant findings (data not
shown). All other wt-ZH501 infected animals appeared
Fig. 1. Mortality curve of rats infected with wt-ZH501, R-ZH501 or R-ΔNSm-ZH501 viruses. Note that all wt-ZH501 and R-ZH501 virus infected animals succumbed
to lethal hepatic disease at 2–3 days PI. R-ΔNSm-ZH501 virus infected animals experienced a biphasic mortality pattern with multiple deaths at days 3–5 PI due to
hepatic disease and later at day 13 with clinically evident neurologic disease confirmed by RVF virus specific RT-PCR and virus isolation.
Fig. 2. RT-PCR detection of RVF virus RNA from early hepatic disease deaths.
RT-PCR amplification of M RNA fragments from whole blood collected from
infected animals. Lanes 1–4: animals from R-ΔNSm-ZH501 101, 102, 103 and
104 PFU dose groups respectively. Lane 5: R-ZH501. Lane 6: wt-ZH501. L: size
markers. Note lack of contamination of R-ΔNSm-ZH501 infected animals with
full length amplification products. Expected product sizes—R-ΔNSm-ZH501
1053 bp and wt and recombinant 1439 bp.
12 Rapid Communicationclinically healthy at day 2 PI and had either maintained or lost
only 1–2 g of total body weight. On the morning of Day 3 post-
infection all 7 remaining wt-ZH501 virus infected rats were
found dead regardless of dose group (Fig. 1). Upon necropsy,
gross pathology indicated extensive diffuse hepatic necrosis
with no other significant findings. These findings demonstrate
the successful establishment of the classic RVF disease model in
our laboratory.
Pathogenesis of recombinant RVF viruses
R-ZH501 virus
To ensure that reverse genetics derived wt virus (R-ZH501)
had the same lethality in rats as authentic wt virus, a total of 6
WF rats in groups of 3 were infected with R-ZH501 at doses of
101 or 103 PFU. These animals remained clinically healthy and
maintained body weight until day 3 PI when 3 animals were
found dead and the other 3 animals had signs of severe clinical
illness (ruffled hair coat, hunched posture, moribund activity)
and were euthanized. All moribund animals had lost significant
weight (7 g–17 g) overnight. The mean time to death of these
animals was identical to those infected with wt-ZH501 virus
regardless of challenge dose (Table 1 and Fig. 1). Gross
pathology at necropsy in all 6 animals indicated extensive
diffuse hepatic necrosis consistent with that found in wt-ZH501
infection in WF rats.
R-ΔNSm-ZH501 virus
To assess the contribution of the NSm proteins to severe
disease in the WF rat model, a total of 18 WF rats were infected
with the R-ΔNSm-ZH501 virus at dosages varying from 101–
104 PFU. Surprisingly, the R-ΔNSm-ZH501 virus was found to
retain virulence for WF rats (Fig. 1 and Table 1). Although the
virus retained lethality in this animal model it was found to be
attenuated compared to wt-ZH501 or R-ZH501 controls. Allanimals regardless of dose began to show signs of clinical
illness (ruffled hair coat, hunched posture, huddling behavior) at
day 3 PI with 1 animal found dead in the 104 PFU dose group.
On the subsequent day (day 4 PI) all animals in each dose group
continued to show signs of clinical illness and weight loss
ranging from 2 to 12 g and a total of 6 animals were found dead.
These animals were found in each dose group with 1 death at
101 PFU, 1 at 102 PFU, 2 at 103 PFU, 2 at 104 PFU (Fig. 1 and
Table 1). At day 5 PI one additional animal (dose group 102
PFU) was found dead and all surviving animals remained
clinically ill. In all 8 early onset deaths, gross pathology at
necropsy indicated extensive diffuse hepatic necrosis that was
consistent with that observed in fatal infections in WF rats with
wt-ZH501 virus. At necropsy, whole blood was collected, and
virus S, M and L segment RNAwas amplified by RT-PCR and
sequenced to ensure that in the cases of lethal R-ΔNSm-ZH501
virus infection that no cross-contamination had inadvertently
occurred with wild type virus (Fig. 2). By day 6 PI all surviving
Fig. 3. Virus isolation and RT-PCR detection of RVF virus from brain
homogenates and whole blood. (A) Virus isolation from RVF virus infected
animal brain homogenates collected at time of death. n.d.=not done. (B) M
segment amplification products from brain homogenates. (C) M segment
amplification products from RVF virus infected animal whole blood. In all
panels: lanes 1–3: R-ΔNSm-ZH501 animals with lethal neurologic disease, lane
4: R-ZH501 (hepatic disease) and lane 5: wt-ZH501 (hepatic disease) infected
animal brain (panel B) or blood (panel C) tissue included for size comparisons.
L: size markers. Note lack of contamination of R-ΔNSm-ZH501 infected
animals with full-length amplification products and the greater amount of R-
ΔNSm-ZH501 amplification product in brain tissue compared to whole blood.
Expected product size R-ΔNSm-ZH501: 1053 bp; wt and recombinant:
1439 bp.
13Rapid Communicationanimals had returned to clinical health and began to demonstrate
consistent daily weight gains. Unexpectedly, at day 13 one rat
was found dead and 2 others were euthanized while displaying
clinical signs of severe neurologic disease (head tilt, head
tremors, lethargy, ataxia). In contrast to R-ZH501 and wt-
ZH501 infected controls, at necropsy these animals had no
evidence of hepatic necrosis and showed no other gross
pathology. In order to confirm that these delayed onset
neurologic deaths were attributable to R-ΔNSm-ZH501 virus
infection, tissues were harvested for RNA extraction (blood and
brain) and virus isolation (brain). In all 3 animals, brain tissue
was strongly positive by both RT-PCR and virus isolation for R-
ΔNSm-ZH501 virus (Fig. 3, Panels A and B). In 2 of the 3
animals results of RT-PCR completed on RNA extracted from
blood samples demonstrated little or no detectable R-ΔNSm-
ZH501 virus RNA (Fig. 3, Panel C). In the remaining animal, a
faint R-ΔNSm-ZH501 virus amplification product was
detected. These results taken together indicate that the virus
detected in brain tissue was primarily due to specific R-ΔNSm-
ZH501 virus replication in brain tissue rather than contamina-
tion from viremic blood. Two additional R-ΔNSm-ZH501
infected animals showed signs of mild neurologic illness (head
tremors) on days 14 and 15 which resolved by day 16. All
remaining animals appeared clinically healthy and continued to
gain weight and the experiment was terminated by euthanizing
all surviving animals on day 21.
Discussion
We report here the development of a highly efficient reverse
genetics system for RVF using only 3 plasmids expressingantigenomic copies of the S, M and L segments, similar to
successful highly efficient systems developed for Bunyamwera
and La Crosse viruses (Lowen et al., 2004; Blakqori and Weber,
2005). This system allowed the rapid generation of both full
length recombinant RVF virus and a mutant virus containing a
deletion of the entire coding region of the NSm gene on the M
segment. We and others have reported the ability of recombi-
nant RVF virus lacking the NSm 14 kDa and 78 kDa proteins to
exhibit growth in cell culture comparable to that of wild type
virus (Gerrard et al., 2007; Won et al., 2006). Having based our
reverse genetics system on the fully virulent ZH501 strain
(isolated in Egypt in 1977 from a fatal human case), we were
able to directly begin in vivo pathogenesis studies in a Wistar-
furth rat model of infection and lethal disease. Central to this
ability was the robustness of the reverse genetics system after
optimization and correction of several inherent difficulties with
the original system, which included lack of efficient full length
S segment virus RNA replication, the requirement of an
expression plasmid for NP, and 2 amino acid coding changes on
the M segment (data not shown).
Our finding of the non-essential nature of the NSm proteins
in mammalian host pathogenesis was surprising. The apparent
importance of NSm proteins was highlighted in a recent
comparative phylogenetic analysis of 33 isolates of diverse RVF
virus from throughout the natural geographic range and
spanning 56 years (1944–2000). The complete conservation
of the 5 in-frame AUG codons found in the NSm coding region
that are utilized to generate either the NSm 14 kDa or NSm+Gn
fusion of 78 kDa suggested an evolutionarily conserved role for
these proteins (Bird et al., 2007). In addition, reverse genetics
attempts to generate Bunyamwera virus similarly completely
lacking its NSm protein failed to even generate infectious virus
(Shi et al., 2006). However, it should be mentioned that the
orthobunyavirus NSm is sandwiched between Gn and Gc
whereas the RVFV NSm is upstream of Gn. Consequently,
although having similar names, the NSm proteins may be
functionally distinct. In addition, the Uukuniemi-like phlebo-
viruses do not have an NSm protein. Also, it had previously
been shown that RVF virus deficient in the expression of the
NSs non-structural protein encoded by the S segment was
completely attenuated in the WF rat model despite its ability to
grow well in tissue culture (Vialat et al., 2000). While the NSm
deficient RVF virus (R-ΔNSm-ZH501) was attenuated, it
retained the ability to cause clinical illness and remained lethal
in 61% of rats infected regardless of challenge dose. The finding
of clinical illness and death at all challenge doses suggests that
within the population of WF rats some animals are more
susceptible to infection with R-ΔNsm-ZH501 virus. This
finding may allow for the elucidation of the precise role of
the NSm proteins in these animals by comparisons of survivor
versus lethal outcomes in future serial bleed and serial sacrifice
studies to address issues of virus load, tissue specific replication
and inherent host factors responsible for survival.
It is surprising that in cell culture both NSs and NSm non-
structural proteins are individually dispensable for RVF virus
replication, assembly and maturation (Gerrard et al., 2007;
Won et al., 2006; Ikegami et al., 2006; Muller et al., 1995).
14 Rapid CommunicationThe complete genome of RVF virus encompasses a total of
11.9 kB and is likely under evolutionary pressure to remove
non-essential genes. The finding that a total of 1.2 kB or
approximately 10% of the total genome is devoted to non-
structural proteins not required for virus growth in cell culture
suggests that strong evolutionary selection operates to
maintain their function. While the NSs coding region, which
functions to antagonize host cell RNA Pol II transcription and
indirectly allow the virus to circumvent the innate host
antiviral response, is essential for virus virulence in vivo, the
role of the NSm coding region and the 2 resultant proteins
remains unknown (Billecocq et al., 2004). Our hypothesis that
R-ΔNSm-ZH501 virus would be rendered highly attenuated
and non-lethal in vivo, similar to a Δ-NSs virus such as the
naturally occurring mutant strain Clone 13 (Vialat et al.,
2000), was proven false by the development of clinical disease
in all animals challenged with 61% progressing to lethal
outcomes. The unexpected finding of delayed onset RVF
neurologic disease ∼2 weeks post-infection without accom-
panying high level viremia mimics late stage encephalitis
observed in a proportion of human or livestock infections
(Meegan et al., 1981; Rippy et al., 1992; Swanepoel and
Coetzer, 1994; Madani et al., 2003). This surprising result
suggests that the use of reverse genetics generated wt or
mutant RVF viruses in WF rats provides a useful model
system to investigate the pathogenesis of both severe rapid
onset hepatic disease and delayed onset neurologic disease in
humans and livestock.
It is clear that while the NSm proteins contribute to in vivo
mammalian pathogenesis they are not essential for lethal
disease. Our finding of the dispensability of the NSm proteins
in mammalian pathogenesis leads towards speculation of
perhaps a more significant role for NSm proteins in arthropod
vectors than in mammalian hosts. Infection and subsequent
transmission of Rift Valley fever virus by arthropod vectors
requires penetration of several cellular membranes including the
mid-gut barrier and avoidance of the innate insect immune
response (Romoser et al., 2005) Perhaps the NSm 14 kDa or the
NSm+Gn 78 kDa fusion protein play a role in vivo in vector
species. Further comparisons using larger numbers of animals
are needed, and may provide insights into the differential innate
and adaptive immune response of survivor animals infected
with R-ΔNSM-ZH501 virus with those succumbing to either
lethal hepatic or neurologic disease and may help elucidate the
as yet undefined role of these evolutionarily conserved NSm
non-structural proteins.
Methods
RVF virus and bio-safety
All work with live virus and infected animals was conducted
within the CDC bio-safety level 4 (BSL-4) laboratory. Working
stocks of low passage of ZH501 wild-type or recombinant RVF
viruses were prepared by passage on Vero E6 monolayers. The
Genbank entries for the RVF virus strain ZH501 S, M and L
genome segment sequences are DQ380149, DQ380200 andDQ375406, respectively. Animal whole blood or 10% brain
homogenates were added to Tripure reagent (Roche) at a ratio of
10:1 for virus inactivation and subsequent RNA extraction in a
BSL-3 laboratory.
Generation of recombinant viruses
Rescue of recombinant viruses was accomplished by
simultaneous liposome mediated transfection of the 3 full
length antigenomic sense plasmids in 1 ug quantities with LT-1
lipofectant (Mirus) at a ratio of 5:1 and transferred onto
subconfluent (∼60%) monolayers of BSR-T7/5 cells stably
expressing the T7 polymerase. BSR-T7/5 cells were a generous
gift from Dr. K. Conzelmann (Max-von Pettenkofer-Institut,
Munchen, Germany). Beginning at 48–72 h post transfection
(DPT) cytopathic effect in the BSR-T7 cells was observed and
after complete monolayer lysis, typically days 4–5 post-
transfection, transfected cell supernatants were clarified by
low speed centrifugation, and passaged twice (dilution 1:500)
onto fresh confluent monolayers of VERO E6 cells. The exact
molecular sequence identity of each rescued virus was
confirmed by complete genome sequencing following techni-
ques described previously (Bird et al., 2007).
Animal infections
A total of 36 female Wistar-furth (WF/NSd) (Harlan) rats
aged 12 weeks old (average=175 g) were used in this study and
were housed in micro-isolator pans and provided food and water
ad libitum. All pans were kept in HEPA filtration rack units
following standard barrier care techniques within a BSL-4
laboratory. All animals were inoculated subcutaneously (SQ) in
the right hind flank. A total of 3 animals served as sham
inoculated (sterile PBS only) controls. Animals were monitored
daily for signs of clinical illness and weight loss. Any animals
found either in severe clinical illness or moribund were
immediately euthanized (isoflurane/sodium pentobarbital).
Whole blood and tissue samples were collected at the time of
euthanasia or from animals found dead, and frozen at −80 C for
later total RNA extraction and virus isolation following stan-
dard techniques. All procedures completed with animals during
this study were approved by the CDC Institutional Animal Care
and Use Committee and the CDC Institutional Bio-Safety
committee.
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